ZENTEC - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.8
| Stock Code | ZENTEC | Market Cap | 12,803 Cr. | Current Price | 1,417 ₹ | High / Low | 2,268 ₹ |
| Stock P/E | 59.3 | Book Value | 195 ₹ | Dividend Yield | 0.14 % | ROCE | 32.9 % |
| ROE | 24.6 % | Face Value | 1.00 ₹ | DMA 50 | 1,373 ₹ | DMA 200 | 1,447 ₹ |
| Chg in FII Hold | -0.40 % | Chg in DII Hold | -0.07 % | PAT Qtr | 47.8 Cr. | PAT Prev Qtr | 46.2 Cr. |
| RSI | 55.9 | MACD | 22.3 | Volume | 5,87,646 | Avg Vol 1Wk | 5,34,539 |
| Low price | 1,223 ₹ | High price | 2,268 ₹ | PEG Ratio | 0.15 | Debt to equity | 0.00 |
| 52w Index | 18.6 % | Qtr Profit Var | 23.8 % | EPS | 23.9 ₹ | Industry PE | 52.9 |
📊 Analysis: ZENTEC demonstrates strong fundamentals with ROCE at 32.9% and ROE at 24.6%, reflecting excellent efficiency and profitability. The stock trades at a premium valuation with a P/E of 59.3 compared to the industry average of 52.9, but a very low PEG ratio of 0.15 suggests undervaluation relative to growth. Dividend yield is modest at 0.14%, offering limited income support. Debt-to-equity is 0.00, ensuring financial stability. Technical indicators (RSI 55.9, MACD 22.3) show bullish momentum, with the stock trading near its 50 DMA and 200 DMA. Quarterly PAT improved slightly (₹46.2 Cr. to ₹47.8 Cr.), supported by EPS of ₹23.9, indicating consistent earnings power.
💰 Entry Price Zone: Ideal accumulation zone lies between ₹1,350 – ₹1,420, near its 50 DMA support, offering a favorable entry point given strong fundamentals.
📈 Exit / Holding Strategy: If already holding, investors should maintain a long-term horizon (5+ years) given strong ROE, ROCE, and growth potential. Exit strategy should be considered only if valuations become excessively stretched or if profitability momentum weakens. A trailing stop-loss near ₹1,300 can protect downside. Long-term investors may hold until PEG ratio rises closer to 1.0, signaling fair valuation.
✅ Positive
- Strong ROCE (32.9%) and ROE (24.6%) highlight excellent efficiency.
- Low PEG ratio (0.15) indicates undervaluation relative to growth.
- Debt-free balance sheet (Debt-to-equity 0.00).
- EPS at ₹23.9 reflects robust earnings power.
⚠️ Limitation
- High P/E (59.3) compared to industry average (52.9).
- Dividend yield is very low at 0.14%, limiting income appeal.
- FII (-0.40%) and DII (-0.07%) holdings reduced, showing weaker institutional sentiment.
📉 Company Negative News
- Stock trading below its 200 DMA (₹1,447), showing technical weakness.
- Institutional investors trimmed positions (FII and DII holdings decreased).
📈 Company Positive News
- Quarterly PAT improved to ₹47.8 Cr. from ₹46.2 Cr.
- MACD positive (22.3), confirming bullish momentum.
- Strong 52-week performance (+18.6%) reflects investor confidence.
🏭 Industry
- Industry P/E at 52.9 reflects high sector valuations.
- ZENTEC trades at a slight premium but justified by strong fundamentals and growth metrics.
🔎 Conclusion
ZENTEC is a fundamentally strong and growth-oriented stock, currently undervalued relative to its earnings potential despite high P/E. Long-term investors can accumulate near ₹1,350–₹1,420 and hold for 5+ years, benefiting from strong ROE, ROCE, and debt-free balance sheet. Existing holders should continue with a long-term horizon, using a trailing stop-loss near ₹1,300 to protect downside.